<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="126202">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02079974</url>
  </required_header>
  <id_info>
    <org_study_id>4169720110</org_study_id>
    <nct_id>NCT02079974</nct_id>
  </id_info>
  <brief_title>Statins: A New Therapeutic Option for Treatment of Patients With Endometriosis</brief_title>
  <official_title>Statins: A New Therapeutic Option for Treatment of Patients With Endometriosis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Dr. Robert F. Casper</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Toronto Centre for Advanced Reproductive Technology</source>
  <oversight_info>
    <authority>Canada: Health Canada</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Endometriosis is a chronic inflammatory disorder leading to painful periods, pain with
      intercourse and infertility.  The available treatment options to alleviate pain involve
      mainly hormonal treatments and surgery.  All current hormonal treatments are effective but
      disrupt the normal variations in reproductive hormones which prevent ovulation, and thus
      pregnancy.  Statins, a group of cholesterol lowering drugs, have anti-inflammatory
      properties which may be helpful also for the pain related to endometriosis.  The
      investigators plan to undertake a pilot study of 10 patients with endometriosis who will
      take pravastatin sodium together with coQ10, which is inhibited by statins, for a period of
      3 months. If this pilot study shows that the statin treatment may decrease pain symptoms in
      endometriosis, then the investigators plan to undertake a larger study to further
      investigate this matter.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      -  Initial grading of pain by a Linear Analogue Scale (LAS) from 1-10

        -  Initial blood biochemistry including liver function test, lipid profile, creatine/BUN,
           creatine kinase

        -  3 months of treatment with statins (Pravastatin) in a dose of 40mg daily

        -  Supplementation with CoQ10 (200mg) daily for 3 months
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date>July 2014</start_date>
  <completion_date type="Anticipated">July 2014</completion_date>
  <primary_completion_date type="Anticipated">July 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>pain</measure>
    <time_frame>3 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>Linear analogue scale for each component of pain (dysmenorrhea; pelvic pain; dyspareunia)</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Endometriosis</condition>
  <arm_group>
    <arm_group_label>Pravastatin</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Pravastatin sodium 20mg PO daily</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Pravastatin</intervention_name>
    <description>20 mg pravastatin sodium daily for 3 months</description>
    <arm_group_label>Pravastatin</arm_group_label>
    <other_name>pravastatin sodium</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  female patients of reproductive age group (18-38 years) with a clinical or surgical
             diagnosis of endometriosis with pain symptoms

        Exclusion Criteria:

          -  use of hormonal suppression for pain control (OCP, GnRHa) within 6-months

          -  history of surgery for endometriosis within 6- months

          -  current renal or hepatic active disease

          -  current or history of myopathic disease

          -  medication that may interact with statins (erythromycin, gemfibrosil, antifungals,
             antiretrovirals, other cholesterol lowering drugs)
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>38 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Robert Casper, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Dept of Obstetrics and Gynecology, University of Toronto</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Mount Sinai Hospital, University of Toronto</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <zip>M5G 1X5</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Robert Casper, MD</last_name>
      <phone>416972-0110</phone>
      <email>casper@lunenfeld.ca</email>
    </contact>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>March 2014</verification_date>
  <lastchanged_date>March 5, 2014</lastchanged_date>
  <firstreceived_date>March 3, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Toronto Centre for Advanced Reproductive Technology</investigator_affiliation>
    <investigator_full_name>Dr. Robert F. Casper</investigator_full_name>
    <investigator_title>Professor, Dept of Obstetrics and Gynecology</investigator_title>
  </responsible_party>
  <keyword>endometriosis</keyword>
  <keyword>pain</keyword>
  <keyword>fertility</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Endometriosis</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Pravastatin</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
